Literature DB >> 11377135

Is insulin an antiinflammatory molecule?

U N Das1.   

Abstract

I suggest that insulin suppresses the secretion and antagonizes the harmful effects of tumor necrosis factor-alpha, macrophage migration-inhibitory factor, and superoxide anion. Therefore, the glucose-insulin-potassium regimen might be beneficial in acute myocardial infarction and useful in the management of patients with septicemia, septic shock, and other inflammatory diseases in which tumor necrosis factor-alpha and macrophage migration-inhibitory factor have important roles.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11377135     DOI： 10.1016/s0899-9007(01)00518-4

Source DB:  PubMed          Journal:  Nutrition        ISSN： 0899-9007            Impact factor:   4.008


  30 in total

1.  Improving outcomes in patients with acute coronary syndromes.

Authors:  Mustafa Tiewala; Alexander Perkevald; Cristina Ogrin; Mary Ann Banerji
Journal:  Curr Diab Rep       Date:  2004-06       Impact factor: 4.810

2.  Glucose-insulin-potassium correlates with hemodynamic improvement in patients with septic myocardial dysfunction.

Authors:  Won-Young Kim; Moon Seong Baek; Young Shin Kim; Jarim Seo; Jin Won Huh; Chae-Man Lim; Younsuck Koh; Sang-Bum Hong
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

3.  [Prevention and therapy of acute renal failure: the importance of metabolic intervention].

Authors:  Wilfred Druml
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

4.  Clinical effects of intensive insulin therapy treating traumatic shock combined with multiple organ dysfunction syndrome.

Authors:  Jundong Du; Hongming Liu; Rong Liu; Yongming Yao; Huabo Jiao; Xiaodong Zhao; Huinan Yin; Zhanliang Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-04-20

5.  Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus?

Authors:  Undurti N Das
Journal:  Front Endocrinol (Lausanne)       Date:  2017-08-02       Impact factor: 5.555

6.  Diabetes is not associated with increased mortality in emergency department patients with sepsis.

Authors:  Philipp Schuetz; Alan E Jones; Michael D Howell; Stephen Trzeciak; Long Ngo; John G Younger; William Aird; Nathan I Shapiro
Journal:  Ann Emerg Med       Date:  2011-06-16       Impact factor: 5.721

Review 7.  Metabolic syndrome X: an inflammatory condition?

Authors:  Undurti N Das
Journal:  Curr Hypertens Rep       Date:  2004-02       Impact factor: 5.369

8.  Control of hyperglycaemia in paediatric intensive care (CHiP): study protocol.

Authors:  Duncan Macrae; John Pappachan; Richard Grieve; Roger Parslow; Simon Nadel; Margrid Schindler; Paul Baines; Peter-Marc Fortune; Zdenek Slavik; Allan Goldman; Ann Truesdale; Helen Betts; Elizabeth Allen; Claire Snowdon; Deborah Percy; Michael Broadhead; Tara Quick; Mark Peters; Kevin Morris; Robert Tasker; Diana Elbourne
Journal:  BMC Pediatr       Date:  2010-02-05       Impact factor: 2.125

9.  Design and Organization of the Dexamethasone, Light Anesthesia and Tight Glucose Control (DeLiT) Trial: a factorial trial evaluating the effects of corticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery.

Authors:  Basem Abdelmalak; Ankit Maheshwari; Edward Mascha; Sunita Srivastava; Theodore Marks; Wh Wilson Tang; Andrea Kurz; Daniel I Sessler
Journal:  BMC Anesthesiol       Date:  2010-06-30       Impact factor: 2.217

10.  A novel function of insulin in rat dermis.

Authors:  Torbjørn Nedrebø; Tine V Karlsen; Gerd S Salvesen; Rolf K Reed
Journal:  J Physiol       Date:  2004-07-02       Impact factor: 5.182
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.